Abdelli N, Thiefin G, Diebold M D, Bouche O, Aucouturier J P, Zeitoun P
Service d'Hépato-Gastroentérologie, CHU Robert-Debré, Reims.
Gastroenterol Clin Biol. 1996;20(5):502-5.
In patients successfully treated for hereditary retinoblastoma, the risk of developing a second non-ocular tumor has been reported. We report the first case of primary hepatic leiomyosarcoma in a 39 year-old woman who has been treated 37 years before for hereditary retinoblastoma of the left eye. The patient presented with right upper quadrant abdominal pain and fever. Histological diagnosis was made by liver biopsy. As surgical resection was impossible, chemotherapy with epirubicin, then ifosfamide, etoposide and cisplatin was performed. The patient died 22 months after diagnosis. Genetic abnormalities observed in hereditary retinoblastoma, which probably resulted in a predisposition to the development of hepatic cancer in this patient, were not investigated.
据报道,遗传性视网膜母细胞瘤成功治疗的患者有发生第二种非眼肿瘤的风险。我们报告了首例原发性肝平滑肌肉瘤病例,患者为一名39岁女性,37年前曾接受过左眼遗传性视网膜母细胞瘤的治疗。患者出现右上腹疼痛和发热症状。通过肝脏活检做出了组织学诊断。由于无法进行手术切除,遂给予表柔比星化疗,随后使用异环磷酰胺、依托泊苷和顺铂进行化疗。患者在诊断后22个月死亡。未对遗传性视网膜母细胞瘤中观察到的基因异常进行研究,这些异常可能是该患者易患肝癌的原因。